Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics

For the quarter ended January 2026, HealthEquity (HQY) reported revenue of $334.59 million, up 7.3% over the same period last year. EPS came in at $0.95, compared to $0.69 in the year-ago quarter.The reported revenue represents a surprise of +0.52% over the Zacks Consensus Estimate of $332.85 million. With the consensus EPS estimate being $0.89, the EPS surprise was +7.09%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total HSA Assets: $36.46 billion versus the three-analyst average estimate of $35.96 billion.HSA Assets - HSA investments: $18.48 billion compared to the $17.66 billion average estimate based on three analysts.Total Accounts - CDBs: 7.22 million versus 7.12 million estimated by three analysts on average.Total Accounts: 17.79 million versus the three-analyst average estimate of 17.52 million.HSA Assets - HSA cash: $17.98 billion compared to the $18.3 billion average estimate based on three analysts.Total Accounts - HSAs: 10.57 million versus 10.49 million estimated by three analysts on average.Revenue- Service: $127.08 million compared to the $123.53 million average estimate based on four analysts. The reported number represents a change of +2.3% year over year.Revenue- Custodial: $161.4 million compared to the $163.24 million average estimate based on four analysts. The reported number represents a change of +12% year over year.Revenue- Interchange: $46.11 million versus the four-analyst average estimate of $45.2 million. The reported number represents a year-over-year change of +6.1%.View all Key Company Metrics for HealthEquity here>>>Shares of HealthEquity have returned +6.5% over the past month versus the Zacks S&P 500 composite's -1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.See Our Newest 5 Stocks Set to Double Picks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HealthEquity, Inc. (HQY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks